HIA
RMD icon

HFM Investment Advisors’s ResMed RMD Stock Holding History

HFM Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36K Buy
7
+3
+75% +$622 ﹤0.01% 616
2026
Q1 		$898 Buy
4
+1
+33% +$249 ﹤0.01% 451
2025
Q4 		$723 Sell
3
-1
-25% -$256 ﹤0.01% 570
2025
Q3 		$1.09K Hold
4
– – ﹤0.01% 330
2025
Q2 		$1.03K Buy
4
+3
+300% +$716 ﹤0.01% 341
2025
Q1 		$224 Buy
+1
New +$233 ﹤0.01% 587

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HFM Investment Advisors's RMD Position: Q2 2026 in Review

HFM Investment Advisors increased its ResMed (RMD) stake by 75% in Q2 2026, buying an estimated $622 and bringing the position to 7 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

HFM Investment Advisors first reported a position in RMD in Q1 2025 and has held it in 6 quarters since. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • HFM Investment Advisors held 7 shares of ResMed worth $1.36K as of Q2 2026.
  • HFM Investment Advisors bought 3 ResMed shares in Q2 2026, an estimated $622.
  • ResMed made up ﹤0.01% of HFM Investment Advisors's portfolio in Q2 2026, its #616 holding.
  • HFM Investment Advisors first reported a position in ResMed in Q1 2025 and has held it in 6 quarters since.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on HFM Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.